- Home
- UHAL vs ASND Comparison
UHAL vs ASND Comparison
Compare UHAL & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UHAL | ASND |
|---|---|---|
| Founded | 1945 | 2006 |
| Country | United States | Denmark |
| Employees | 35100 | N/A |
| Industry | Rental/Leasing Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 12.2B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | UHAL | ASND |
|---|---|---|
| Price | $52.77 | $205.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $256.27 |
| AVG Volume (30 Days) | 193.4K | ★ 640.2K |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.19 | N/A |
| Revenue | ★ $5,972,459,000.00 | $758,592,045.00 |
| Revenue This Year | $6.61 | $99.74 |
| Revenue Next Year | $4.20 | $79.40 |
| P/E Ratio | $44.19 | ★ N/A |
| Revenue Growth | 5.86 | ★ 97.46 |
| 52 Week Low | $48.48 | $118.03 |
| 52 Week High | $75.19 | $223.19 |
Technical Indicators
Market Signals| Indicator | UHAL | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 49.51 | 49.03 |
| Support Level | $48.48 | $198.30 |
| Resistance Level | $54.39 | $218.50 |
| Average True Range (ATR) | 1.26 | 9.16 |
| MACD | 0.42 | -0.64 |
| Stochastic Oscillator | 68.10 | 28.05 |
Price Performance
Historical ComparisonAbout UHAL U-Haul Holding Company
U-Haul Holding Co is an American moving truck, trailer, and self-storage rental company. The company also provides moving boxes, packing supplies, LPG (propane) refills, trailer hitch and wiring installation, storage container rentals, and other services. It has three reportable segments Moving and Storage, Property and Casualty Insurance, and Life Insurance. The majority of its revenue comes from the Moving and Storage segment.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.